EDSA · Categories · Form 4

EDSA - SEC Form 4 insider transactions

Edesa Biotech Inc. (EDSA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for EDSA

• 7d
  Chief Executive Officer Nijhawan Pardeep was granted 1,671 shares, increasing direct ownership by 0.23% to 731,134 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 10d
  Director Marshall Patrick was granted 19,000 shares, increasing direct ownership by 36% to 71,666 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 10d
  Director Macdonald Sean Arthur was granted 19,000 shares, increasing direct ownership by 86% to 41,054 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 10d
  Director Chypyha Joan was granted 19,000 shares, increasing direct ownership by 172% to 30,029 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 10d
  Chief Financial Officer Weiler Peter J. was granted 64,609 shares, increasing direct ownership by 99% to 129,609 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 10d
  President Brooks Michael J was granted 64,609 shares, increasing direct ownership by 28% to 291,479 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 10d
  Director Sistilli Carlo was granted 19,000 shares, increasing direct ownership by 62% to 49,417 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 10d
  Director Olson Charles V was granted 19,000 shares, increasing direct ownership by 173% to 30,000 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 10d
  Chief Executive Officer Nijhawan Pardeep was granted 96,913 shares, increasing direct ownership by 15% to 729,463 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 10d
  Director Liu Da David was granted 19,000 shares, increasing direct ownership by 345% to 24,501 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 38d
  Chief Executive Officer Nijhawan Pardeep was granted 1,159 shares, increasing direct ownership by 0.18% to 632,550 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 59d
  SEC Form 4 filed by Nijhawan Pardeep

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 89d
  SEC Form 4 filed by Edesa Biotech Inc.

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 98d
  Chief Executive Officer Nijhawan Pardeep was granted 82,236 shares, increasing direct ownership by 16% to 595,226 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 126d
  Chief Executive Officer Nijhawan Pardeep was granted 11,168 shares, increasing direct ownership by 2% to 512,990 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 154d
  Chief Executive Officer Nijhawan Pardeep was granted 10,444 shares, increasing direct ownership by 2% to 501,822 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 188d
  Chief Executive Officer Nijhawan Pardeep was granted 8,766 shares, increasing direct ownership by 2% to 491,378 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 214d
  Chief Executive Officer Nijhawan Pardeep was granted 6,968 shares, increasing direct ownership by 1% to 482,612 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 248d
  Chief Executive Officer Nijhawan Pardeep was granted 5,908 shares, increasing direct ownership by 1% to 475,644 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 269d
  Chief Executive Officer Nijhawan Pardeep was granted 5,981 shares, increasing direct ownership by 1% to 469,736 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 308d
  Chief Executive Officer Nijhawan Pardeep was granted 6,802 shares, increasing direct ownership by 1% to 463,755 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 341d
  Chief Executive Officer Nijhawan Pardeep was granted 7,186 shares, increasing direct ownership by 2% to 456,953 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 371d
  Director Marshall Patrick was granted 11,000 shares, increasing direct ownership by 26% to 52,666 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 371d
  Director Olson Charles V was granted 11,000 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 371d
  Director Sistilli Carlo was granted 20,001 shares, increasing direct ownership by 192% to 30,417 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 371d
  Chief Executive Officer Nijhawan Pardeep was granted 270,844 shares, increasing direct ownership by 151% to 449,767 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 371d
  Director Macdonald Sean Arthur was granted 20,001 shares, increasing direct ownership by 974% to 22,054 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 371d
  Director Chypyha Joan was granted 11,000 shares, increasing direct ownership by 37,931% to 11,029 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 371d
  President Brooks Michael J was granted 207,201 shares, increasing direct ownership by 1,173% to 224,870 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 371d
  Chief Financial Officer Weiler Peter J. was granted 65,000 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 371d
  Director Liu Da David was granted 5,501 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 398d
  Chief Executive Officer Nijhawan Pardeep was granted 6,392 shares, increasing direct ownership by 4% to 178,923 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 431d
  Chief Executive Officer Nijhawan Pardeep was granted 5,784 shares, increasing direct ownership by 3% to 172,531 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 462d
  Chief Executive Officer Nijhawan Pardeep was granted 6,339 shares, increasing direct ownership by 4% to 166,747 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 479d
  Director Sistilli Carlo was granted 10,416 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 479d
  SEC Form 4 filed by Chief Executive Officer Nijhawan Pardeep

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 479d
  Director Marshall Patrick was granted 41,666 shares (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 489d
  Chief Executive Officer Nijhawan Pardeep was granted 8,264 shares, increasing direct ownership by 5% to 160,408 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 518d
  Chief Executive Officer Nijhawan Pardeep was granted 8,476 shares, increasing direct ownership by 6% to 152,144 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 552d
  Chief Executive Officer Nijhawan Pardeep was granted 6,420 shares, increasing direct ownership by 5% to 143,668 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 573d
  Chief Executive Officer Nijhawan Pardeep was granted 4,630 shares, increasing direct ownership by 3% to 137,248 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 584d
  SEC Form 4 filed by Chief Executive Officer Nijhawan Pardeep

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 614d
  Chief Executive Officer Nijhawan Pardeep was granted 3,300 shares, increasing direct ownership by 3% to 132,618 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 643d
  Chief Executive Officer Nijhawan Pardeep was granted 3,055 shares, increasing direct ownership by 2% to 129,318 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 675d
  Chief Executive Officer Nijhawan Pardeep was granted 3,317 shares, increasing direct ownership by 3% to 126,263 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 705d
  Chief Executive Officer Nijhawan Pardeep was granted 4,015 shares, increasing direct ownership by 3% to 122,946 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 734d
  Nijhawan Pardeep was granted 4,785 shares, increasing direct ownership by 4% to 118,931 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 768d
  Nijhawan Pardeep was granted 3,083 units of Common Share, increasing direct ownership by 3% to 114,146 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 797d
  Nijhawan Pardeep was granted 3,253 shares, increasing direct ownership by 3% to 111,063 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 829d
  Nijhawan Pardeep was granted 2,765 shares, increasing direct ownership by 3% to 107,810 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 857d
  Nijhawan Pardeep was granted 2,978 shares, increasing direct ownership by 3% to 105,045 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 878d
  Nijhawan Pardeep was granted 2,908 shares, increasing direct ownership by 3% to 102,067 units (SEC Form 4)

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 1040d
  SEC Form 4: Nijhawan Pardeep was granted 99,300 shares, increasing direct ownership by 17% to 694,112 units

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 1040d
  SEC Form 4: Brooks Michael J was granted 93,200 shares, increasing direct ownership by 306% to 123,680 units

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 1040d
  SEC Form 4: Lemieux Stephen was granted 17,400 shares

  4 - Edesa Biotech, Inc. (0001540159) (Issuer)
• 1050d
  SEC Form 4 filed by Olson Charles V (Amendment)

  4/A - Edesa Biotech, Inc. (0001540159) (Issuer)
• 1050d
  SEC Form 4 filed by Brooks Michael J (Amendment)

  4/A - Edesa Biotech, Inc. (0001540159) (Issuer)
• 1050d
  SEC Form 4 filed by Oakes Frank R. (Amendment)

  4/A - Edesa Biotech, Inc. (0001540159) (Issuer)
• 1050d
  SEC Form 4 filed by Sistilli Carlo (Amendment)

  4/A - Edesa Biotech, Inc. (0001540159) (Issuer)
• 1050d
  SEC Form 4 filed by Chypyha Joan (Amendment)

  4/A - Edesa Biotech, Inc. (0001540159) (Issuer)

Other EDSA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends